Acting Director, NIH Releases Biennial Report

Raynard S. Kington, acting director of the National Institutes of Health (NIH), has issued his first Biennial Report of the Director.  The report provides an overview of NIH research activities, and is intended to help Congress, advocates and patient groups, and the general public to understand the agency’s programs. It contains an assessment of the state of biomedical and behavioral research organized by disease category, investigative approach, or resource.

Read a synopsis of the contents, or  from the synopsis web page download the complete report.

Targeting Cancer’s Own Stem Cells to Fight Recurrence

New research demonstrates that cancer stem cells or “tumor-initiating cells,”  when targeted with a reprogrammed herpes virus, can be prevented from turning malignant and re-initiating disease.  The finding bolsters the theory that cancer harbors its own secret cache of stem cells that are resistant to conventional therapies and responsible for tumor re-emergence.  This type of virus-against-cancer therapy may be the next generation of anti-cancer treatments.  The study was published online Jan. 21 in the journal PLoS (Public Library of Science) One.